Fierce Biotech July 5, 2022
Andrea Park

True to its name, Orchestra BioMed is currently conducting a symphony of several business ventures at once.

In a three-in-one announcement Tuesday, the Pennsylvania-based startup unveiled a new partnership with Medtronic, the close of its latest funding round and—backed in part by the proceeds from that financing—plans to go public through a SPAC merger.

“These significant transactions further validate the potential of Orchestra BioMed’s flagship development programs and our novel partnership-enabled business model,” said David Hochman, the company’s chairman, CEO and co-founder. “The capital proceeds from our series D financing and planned business combination provide Orchestra BioMed with a substantial financial runway and position us to achieve major milestones.”

The first movement includes the Medtronic team-up....

Today's Sponsors

Oliver Wyman
Patient Bond
pCare

Today's Sponsors

Amwell
Oliver Wyman

Today's Sponsor

Patient Bond

 
Topics: Biotechnology, Mergers & Acquisitions / JV, Pharma / Biotech, Trends
Record-breaking deals, partnerships and more: 7 California ASC updates
Psychedelics Co. Silo Wellness To Acquire Dyscovry Science, Seeking To Leverage Its Govt. Partnerships
7 ASC acquisitions, affiliations, partnerships
Home-Based Care Acquisitions, Partnerships Both on Table for CVS Health
GE Healthcare, Circle Health Group enter 10-year partnership deal to empower UK clinicians through technology and data